eperisone

Also known as (2RS)-1-(4-ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one, Eperisonum, Eperison, Eperisona, Epérisone

Eperisone (formulated as the eperisone hydrochloride salt) is an antispasmodic drug.

Key facts

Drug.Verifiedfields: changed
Drug.Watchedfields: changed
Drug.verifiedrevid: 477167014
Drug.IUPAC_name: (2RS)-1-(4-Ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one
Drug.image: Eperisone.png
Drug.image_class: skin-invert-image
Drug.image2: Eperisone3d.png
Drug.image_class2: bg-transparent
Drug.tradename: Myonal
Drug.legal_status: Rx-only
Drug.routes_of_administration: Oral
Drug.index2_label: HCl
Drug.CAS_number

Article

15 sections

Contents

Indications
Presentation
Dosage and administration
Safety during pregnancy and breast-feeding
Pharmacology
Contraindications
Cautions
Side effects
Drug interactions
Safety in overdose
Future developments
Brand names
See also
References
Further reading

Eperisone (formulated as the eperisone hydrochloride salt) is an antispasmodic drug.

Eperisone acts by relaxing both skeletal muscles and vascular smooth muscles, and demonstrates a variety of effects such as reduction of myotonia, improvement of circulation, and suppression of the pain reflex. The drug inhibits the vicious circle of myotonia by decreasing pain, ischaemia, and hypertonia in skeletal muscles, thus alleviating stiffness and spasticity, and facilitating muscle movement